drugset / Trial / NCT00352651

Study to Find Out if Therapy With the Drug Pregabalin Relieves Pain During Shingles Compared With Placebo

NCT00352651 ↗

RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to see if therapy with the drug pregabalin relieves pain during shingles compared with placebo. A placebo is an inactive substance. Pregabalin is a drug marketed as Lyrica™ in the United States for the treatment of seizures, diabetic neuropathy, and post-herpetic neuralgia. The use of pregabalin and drugs like it for the treatment of pain during the acute phase of shingles is experimental. Thirty four subjects will complete the study at the University of California, San Francisco (UCSF) Pain Clinical Research Center. This study is funded by Pfizer Global Research.

Timeline

Start
2006-06
Primary completion
2006-12
Completion
2006-12

Outcome

Outcome not reported

Stopped: “This study should be terminated as the study has been closed for years and the investigator has since retired. No records are available. Thank you, Marlene”

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg Oral